- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03945890
Importing Quality Improvement Practices and Enhance Health Education to Improving Quality of Bowel Preparation
Health Management Center, Far Eastern Memorial Hospital
Importing quality improvement practices and enhances health education to improving quality of bowel preparation for health screening colonoscopy
This is a retrospective data analysis study aimed at obtaining the types of purgative treatments used, the results of bowel preparation, and each subject's demographic characteristics (Age & Gender).
Study Overview
Detailed Description
This study aimed to check-up the result and the impact of patient education using a medical team resource management (TRM) method on the adequacy of bowel preparation.
Investigators collected a total of 2,104 (884 female, 1,220 male) healthy subjects who underwent a health check-up colonoscopy screening were enrolled before and after the application of the TRM program intervention. The efficacy of the TRM intervention and the factors affecting bowel preparation were estimated using multivariate logistic regression in this study.
Enrollment of study subjects and data collection: The subjects enrolled in this study were those who received a health check-up colonoscopy screening in a tertiary center, Far Eastern Memorial Hospital (FEMH), in Taiwan from March 2013 to August 2014. A total of 2,104 healthy subjects who underwent check-up colonoscopy screening were enrolled during the pre-intervention, post-intervention, and validation periods. Investigators need to collect each subject's demographic characteristics (Age & Gender) and the types of purgative treatments used were collected to analyze. According to the Aronchick Bowel Preparation Scale, this study divided the degree of bowel cleansing into four levels, namely, "Excellent", "Good", "Fair" and "Poor". Investigators also need to collect the results of bowel preparation to calculate of the adequate bowel cleansing rate was defined further as the percentage of the participants with "Excellent" or "Good" cleansing in our analysis.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pan-Chiao Dist.
-
New Taipei City, Pan-Chiao Dist., Taiwan, 22061
- Oriental Institute of Technology / Far Eastern Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The healthy population who received a health check-up colonoscopy screening in Far Eastern Memorial Hospital (FEMH)
- Exam date from March 2013 to August 2014
- Age from 20 y/o to 80 y/o
Exclusion Criteria:
- Gastroenterology outpatients/inpatients
- Missing data subjects
- Out of the Age limits subjects
- Out of the Time period subjects
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The well-designed education intervention can improve the rate of adequate bowel pr eparation for health screening colonoscopy.
Time Frame: From March 2013 to August 2014.
|
The multivariate logistic regression analysis results for adequate bowel preparation after adjustments for age, gender, purgative type, to analyze the adequate bowel preparation rate with different intervention period. Bowel preparation rate were the Good & Excellent % of the total cases. Each subject's demographic characteristics (Age & Gender), the type of purgative and bowel preparation rate were collected from Far Eastern Memorial Hospital (FEMH) in Taiwan. This study was secondary data analysis, and the data contains no person's details, images, or videos. This is a retrospective data analysis study, investigators collected data enrolled in this study were those who received a health check-up colonoscopy screening. |
From March 2013 to August 2014.
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 104107-E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on No-Show Patients
-
Hospital Italiano de Buenos AiresRecruitingReminder Systems | No-Show PatientsArgentina
-
Hospital General de Niños Pedro de ElizaldeCompletedNo-Show Patients | Non-Attendance, Patient
-
Johns Hopkins UniversityWithdrawnEngagement, Patient | Utilization, Health Care | No-Show PatientsUnited States
-
University of Wisconsin, MadisonMedical College of Wisconsin; National Institute of Dental and Craniofacial... and other collaboratorsCompleted
-
TriHealth Inc.UnknownRace Concordant Patient-provider Relationship | Race Discordant Patient-provider Relationship | Rate of No-show at Follow-up VisitsUnited States
-
Siriraj HospitalMahidol UniversityCompletedAll Hospitalzied Patients | No Specific Conditions RequiresThailand
-
California Polytechnic State University-San Luis...Completed
-
Chulalongkorn UniversityCompletedPatients With Body Temperature Between 37.8-38.5 | No Sign of Infection | No Liver and Kidney ProblemThailand
-
Cairo UniversityNot yet recruitingShow Positive Effect of Radiofrequancy on Postmenopausal Adipose Tissue
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States